noesisnoesis
Well-Being & Mental HealthScientificDE · EN · ES · FR · IT · PT

GAD-7: Generalized Anxiety Disorder ScaleGAD-7

~3 min · 7 questions · Free partial report

A 7-item anxiety screening tool that measures the severity of generalized anxiety symptoms over the past 2 weeks. The GAD-7 is one of the most widely used anxiety screeners in clinical practice, validated for detecting generalized anxiety disorder, social anxiety, panic disorder, and PTSD.

The most widely used anxiety screener in clinical practice, validated for generalized anxiety, panic, social anxiety, and PTSD.

What you'll discover
  • Screen for anxiety symptoms and assess their severity. The GAD-7 can help identify whether anxiety is affecting your daily life and whether professional support may be beneficial.

No signup required to start. The Partial Report is free at the end. The Complete costs $0.00, if and when you want it.

What this test measures

What this test measures

A

Anxiety

Tendency to experience worry, nervousness, and fear. Anxious individuals feel tense, jittery, and anticipate danger even when none is present.

CalmAnxious

Discover where you stand on each dimension.

Start for free

No prior signup. Free partial result immediately.

How it works

From first click to report.

The process is simple: you respond, the system calculates, and the result appears. No prior signup, no form, no waiting.

  1. 1

    Click "Start for free"

    No signup required to start. You identify yourself at the end, when you want to save the result. The test opens immediately.

  2. 2

    Answer the questions

    One at a time, scale of 1 to 5. Visible progress bar. You can pause and resume from any device after identifying yourself.

  3. 3

    Get the Partial Report

    Immediate and free. A text summary of each dimension, with indication of high, medium, or low.

  4. 4

    Decide if you want the Complete

    The Partial already delivers value. The Complete adds percentiles, norm comparison, charts, applied recommendations, and a verifiable Certificate.

  5. 5

    Explore in the Integrative Chat

    Talk to an AI about your results. Ask how your profile applies to your career, what a high score means, or compare with other tests.

Average time per step
~3 minAnswer the questions. Real user median.
~3 secFor the Partial Report to appear after the last answer.
~30 secTo generate the personalized Complete Report (3 to 5 paragraphs per dimension).
1 yrAccess to the report and Integrative Chat.
Free and paid, side by side

The Partial is yours right away. The Complete, when it makes sense.

Free and paid, side by sidePartial Report (free, always)Complete Report ($0.00)
Interpretive text per dimension, generated from your answers
Raw score for each dimension
One-paragraph overview reading
Everything in the Partial, expanded to 3–5 paragraphs per dimension
Percentile per dimension, compared to reference norms
Inter-dimensional chart with accessible data table
Applied recommendations: career, relationships, self-care
Certificate with public verification and PDF download
Individual Complete Report
$0.00
  • Everything in the Partial, expanded to 3–5 paragraphs per dimension
  • Percentile per dimension, compared to reference norms
  • Applied recommendations: career, relationships, self-care
  • Certificate with public verification and PDF download
Buy Complete Report

You only pay after completing the test, if you want to go beyond the Partial.

Free Partial Report
Free
  • Interpretive text per dimension, generated from your answers
  • Raw score for each dimension
  • One-paragraph overview reading
Start for free

Payment via PIX (instant) or credit card. Access for 1 year. After that, the report stays visible in read-only mode.

Scientific basis

Why trust this instrument.

The GAD-7 (Spitzer, Kroenke, Williams & Löwe, 2006) measures the severity of generalized anxiety symptoms over the past two weeks using 7 items scored 0-3. Total scores range from 0 to 21 with established severity cutoffs (minimal, mild, moderate, severe). At a cutoff of 10, it has 89% sensitivity and 82% specificity for generalized anxiety disorder, and also shows good sensitivity for panic disorder, social anxiety disorder, and PTSD.

Authors:
Spitzer, Kroenke, Williams, & Lowe
Year:
2006
Origin:
US
Convergent Validity
Convergent ValiditySensitivity 89%, specificity 82% for GAD; also sensitive to panic, social anxiety, and PTSD
Discriminant ValidityStrong correlation with functional impairment; responsive to clinical change
References
  • Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092-1097.
Scientific foundation

The theory behind this test.

PRIME-MD / PHQ Clinical Screening Framework

Clinical screening framework derived from the Primary Care Evaluation of Mental Disorders (PRIME-MD). Operationalizes DSM-IV diagnostic criteria into brief self-report screeners for depression (PHQ-9/PHQ-2), anxiety (GAD-7), somatization (PHQ-15), and other conditions. Not a diagnostic system — designed to identify probable cases for clinical follow-up.

Learn more about this theory
Who is this for

Target Audience

Adults (18+) who want to screen for or monitor anxiety symptoms

RecruitmentClinicalEducation

Recommended ages: 18+

What you will discover

Questions the report answers.

  • A

    How severe are your anxiety symptoms?

    Scores of 0-4 suggest minimal anxiety, 5-9 mild, 10-14 moderate, and 15-21 severe anxiety. Higher scores indicate greater symptom burden across worry, restlessness, and associated symptoms.

    Who is this for

    Who benefits most.

    Anxiety self-screeners

    Individuals who suspect they may be experiencing problematic anxiety and want a quick, validated screening tool.

    Treatment monitors

    People in therapy or medication treatment for anxiety who want to track their symptom severity over time.

    Frequently asked questions

    Frequently asked questions

    What does this test measure?

    It measures the severity of generalized anxiety symptoms over the past 2 weeks, including worry, restlessness, irritability, and difficulty relaxing.

    How long does it take?

    About 2-3 minutes. It has only 7 items.

    Is this test scientifically validated?

    Yes. The GAD-7 has excellent psychometric properties with a sensitivity of 89% and specificity of 82% for generalized anxiety disorder at a cutoff score of 10 (Spitzer et al., 2006).

    Does this only detect generalized anxiety?

    While designed for GAD, the GAD-7 has good sensitivity for detecting panic disorder, social anxiety disorder, and post-traumatic stress disorder as well.

    Combine instruments for a fuller profile.

    Each test measures different dimensions. The Integrative Chat crosses the results of all tests you complete, revealing connections no single instrument can show.

    Well-Being & Mental HealthNew

    Optimism Test

    ~3 min·10 questions

    Measure your natural tendency toward optimism or pessimism.

    Start for free
    Well-Being & Mental HealthNew

    Perceived Stress Assessment

    ~3 min·10 questions

    Measure how stressed you feel about your life right now.

    Start for free
    Well-Being & Mental HealthNew

    Mindfulness Assessment

    ~4 min·15 questions

    Explore your mindfulness across five key facets.

    Start for free
    Well-Being & Mental HealthNew

    Flourishing Assessment

    ~7 min·23 questions

    Measure your overall well-being across the five pillars of flourishing.

    Start for free

    GAD-7: Generalized Anxiety Disorder Scale

    No signup, no time limit. The Partial is free at the end.

    The Complete costs $0.00, if and when you want it.

    This test is a self-knowledge tool for informational purposes. It does not constitute a psychological or clinical diagnosis and does not replace evaluation by a qualified professional. The report indicates the AI model used in text generation.

    The GAD-7 was developed by Drs. Robert L. Spitzer, Kurt Kroenke, Janet B.W. Williams, and Bernd Lowe with an educational grant from Pfizer Inc. No permission is required to reproduce, translate, display, or distribute.

    Start for freeBuy Complete Report